» Articles » PMID: 22853875

A Nomogram Associated with High Probability of Malignant Nodes in the Surgical Specimen After Trimodality Therapy of Patients with Oesophageal Cancer

Abstract

Background: The presence of malignant lymph nodes (+ypNodes) in the surgical specimen after preoperative chemoradiation (trimodality) in patients with oesophageal cancer (EC) portends a poor prognosis for overall survival (OS) and disease-free survival (DFS). Currently, none of the clinical variables highly correlates with +ypNodes. We hypothesised that a combination of clinical variables could generate a model that associates with high likelihood of +ypNodes after trimodality in EC patients.

Methods: We report on 293 consecutive EC patients who received trimodality therapy. A multivariate logistic regression analysis that included pretreatment and post-chemoradiation variables identified independent variables that were used to construct a nomogram for +ypNodes after trimodality in EC patients.

Results: Of 293 patients, 91 (31.1%) had +ypNodes. OS (p=0.0002) and DFS (p<0.0001) were shorter in patients with +ypNodes compared to those with -ypNodes. In multivariable analysis, the significant variables for +ypNodes were: baseline T-stage (odds ratio [OR], 7.145; 95% confidence interval [CI], 1.381-36.969; p=0.019), baseline N-stage (OR, 2.246; 95% CI, 1.024-4.926; p=0.044), tumour length (OR, 1.178; 95% CI, 1.024-1.357; p=0.022), induction chemotherapy (OR, 0.471; 95% CI, 0.242-0.915; p=0.026), nodal uptake on post-chemoradiation positron emission tomography (OR, 2.923; 95% CI, 1.007-8.485; p=0.049) and enlarged node(s) on post-chemoradiation computerised tomography (OR, 3.465; 95% CI, 1.549-7.753; p=0.002). The nomogram after internal validation using the bootstrap method (200 runs) yielded a high concordance index of 0.756.

Conclusion: Our nomogram highly correlates with the presence of +ypNodes after chemoradiation, however, considerably more refinement is needed before it can be implemented in the clinic.

Citing Articles

Development of a Nomogram to Predict the Outcome for Patients with Soft Tissue Sarcoma.

Bray J, Munday J Vet Sci. 2023; 10(4).

PMID: 37104421 PMC: 10146366. DOI: 10.3390/vetsci10040266.


A Novel RNA-Seq-Based Model for Preoperative Prediction of Lymph Node Metastasis in Oral Squamous Cell Carcinoma.

Qiao B, Zhao M, Wu J, Wu H, Zhao Y, Meng F Biomed Res Int. 2020; 2020:4252580.

PMID: 32934959 PMC: 7479460. DOI: 10.1155/2020/4252580.


Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study.

Wang G, Chang Y, Wu X, Li X, Li L, Zhang M Oncol Lett. 2019; 18(4):3493-3500.

PMID: 31516567 PMC: 6732941. DOI: 10.3892/ol.2019.10719.


Development of a preoperative prediction nomogram for lymph node metastasis in colorectal cancer based on a novel serum miRNA signature and CT scans.

Qu A, Yang Y, Zhang X, Wang W, Liu Y, Zheng G EBioMedicine. 2018; 37:125-133.

PMID: 30314890 PMC: 6284350. DOI: 10.1016/j.ebiom.2018.09.052.


Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using F-FDG PET/CT.

Goense L, Ruurda J, Carter B, Fang P, Ho L, Meijer G Eur J Nucl Med Mol Imaging. 2018; 45(10):1742-1751.

PMID: 29663014 PMC: 6097755. DOI: 10.1007/s00259-018-4011-6.


References
1.
Javeri H, Arora R, Correa A, Hofstetter W, Lee J, Liao Z . Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer. 2008; 113(6):1302-8. DOI: 10.1002/cncr.23688. View

2.
Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M . Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer. Ann Nucl Med. 2009; 23(1):73-80. DOI: 10.1007/s12149-008-0209-1. View

3.
Harrell Jr F, Lee K, Mark D . Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15(4):361-87. DOI: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4. View

4.
Sjoquist K, Burmeister B, Smithers B, Zalcberg J, Simes R, Barbour A . Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011; 12(7):681-92. DOI: 10.1016/S1470-2045(11)70142-5. View

5.
Mariette C, Taillier G, Van Seuningen I, Triboulet J . Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004; 78(4):1177-83. DOI: 10.1016/j.athoracsur.2004.02.068. View